NTA releases fresh exam dates for UGC NET December 2020 and July 2021 cycle; check notification here

-

The National Testing Agency (NTA) has announced new dates for the University Grants Commission National Eligibility Test (UGC NET) December 2020 and June 2021 cycle. Candidates had voiced their concerns regarding the postponement of the exam after which the agency has finally announced the new exam dates.

According to the new schedule, the test will be conducted on 20, 21, 22, 24, 25, 26, 29, 30 November, and 1, 3, 4, and 5 December.

Check official notification here.

The detailed schedule and admit cards for the exam will soon be made available on NTA’s official portal. Candidates need to keep a check on the websites https://nta.ac.in/ and https://ift.tt/2OGIMss for updates regarding the hall tickets.

UGC releases admit cards around 10 days before the exam date. Candidates facing any issues can also contact the NTA help desk at 011-40759000 or can write to ugcnet@nta.ac.in.

UGC NET is conducted twice a year, where one cycle is conducted in June and the second one is held in December. The December 2020 exam was postponed due to COVID-19 and hence has been merged with the June 2021 exam cycle. The test was to be held from 17 October, however, the agency pushed it ahead as the dates were coinciding with several important and major exams.

This was not the first time when the UGC NET exam dates were postponed. Earlier, it was supposed to be held in September. It has been delayed four times in the past 10 months.

Using the hashtag #ReleaseNETEXAMDATE, a number of candidates had tweeted and requested the Education Minister to release the final dates along with prior notice of 30 days as they want to prepare themselves for the test.

UGC NET is a computer-based three-hour test where there are 50 questions in Paper I while Paper II comprises 100 questions. This exam determines the eligibility of candidates for Junior Research Fellowship (JRF) and Assistant Professorship. Those who qualify the exam are eligible for the post of Assistant Professor in colleges.

 



from Firstpost India Latest News https://ift.tt/3nnVs79
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more